What is OrthoPets?
Founded in 2003 by Martin Kaufmann, a specialist in orthotics and prosthetics, OrthoPets has become the preeminent provider of custom orthotic and prosthetic devices for animals. With a legacy spanning over two decades and a treatment history encompassing more than 30,000 pets across 35 countries, the Colorado-based company is at the forefront of advancing the VOP industry through research, publications, and educational outreach to veterinarians. Its expertise in designing, fabricating, and fitting specialized devices addresses a critical need in animal rehabilitation and mobility.
How much funding has OrthoPets raised?
OrthoPets has raised a total of $102K across 1 funding round:
Debt
$102K
Debt (2021): $102K with participation from PPP
What's next for OrthoPets?
The substantial capital infusion, particularly the recent strategic investment, positions OrthoPets for accelerated growth and market penetration. As a company operating in a large-scale, late-stage funding environment, this backing is likely earmarked for expanding operational capacity, enhancing research and development initiatives, and potentially broadening its global reach. The strategic nature of the investment suggests a focus on synergistic opportunities that could further solidify OrthoPets' dominance in the veterinary orthotics and prosthetics sector, potentially through new product development or strategic partnerships.
See full OrthoPets company page
